In the Zwolle Outpatient Diabetes project Integrating Available Care (ZODIAC) cohort (756 patients with T2DM followed-up for 6.5 years), plasma copeptin levels were also associated with a decline in GFR but only in patients not using RAS inhibitors [54]. Here, AVP is linked to type 2 diabetes mellitus.